reports
Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents...
A director at Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents sold 303,441 shares at 0.000EGP and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all ...
Amicogen Inc: 4 directors
Two Directors at Amicogen Inc bought 9,040 shares at between 3,492.000KRW and 3,496.000KRW. The significance rating of the trade was 35/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over ...
- Lindsay Whipp
PSA: Enterprise Software: SMID-Cap IT Services Valuations-Growth Gap
PSA: Enterprise Software: SMID-Cap IT Services Valuations-Growth Gap Looking for opportunities in SMID-cap IT services and SaaS companies with significant gaps between valuations and growth among those well positioned for growth in a changing world.
- Felix Fischer
- Jayanth Kandalam
- Si Yong Ng
- Tanvi Arora
Lucror Analytics - Morning Views Europe
In today's Morning Views publication we comment on developments of the following high yield issuers: Recordati, Manuchar, Forvia (formerly Faurecia), EVOCA, Boparan, Alain Afflelou, Oriflame
DraftKings Inc: 1 director
A director at DraftKings Inc sold/sold after exercising options 105,554 shares at 37.621USD and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors o...
Cosmo Pharmaceuticals N.V.: 1 director
A director at Cosmo Pharmaceuticals N.V. bought 3,000 shares at 55.252CHF and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...
Galderma Group AG: 1 director
A director at Galderma Group AG sold 86,731 shares at 91.808CHF and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
Santos Limited: 1 director
A director at Santos Limited bought 30,000 shares at 6.200USD and the significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
Plaza S.A.: 1 director
A director at Plaza S.A. sold 38,460 shares at 1,950.000CLP and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
Santana Minerals Limited: 1 director
A director at Santana Minerals Limited maiden bought 200,000 shares at 0.564AUD and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...
Reddit Inc: 1 director
A director at Reddit Inc sold/sold after exercising options 124,408 shares at 127.357USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over...
OppFi Inc: 1 director
A director at OppFi Inc sold 159,321 shares at 9.130USD and the significance rating of the trade was 82/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showi...
CompoSecure Inc: 1 director
A director at CompoSecure Inc maiden bought 45,045 shares at 11.120USD and the significance rating of the trade was 95/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
Hims & Hers Health Inc: 4 directors
Five Directors at Hims & Hers Health Inc bought/sold after exercising options/sold 293,447 shares at between 0.000USD and 34.310USD. The significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary tr...
Workday Inc: 1 director
A director at Workday Inc sold 86,672 shares at 247.645USD and the significance rating of the trade was 79/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
Fractyl Health Inc: 2 directors
Two Directors at Fractyl Health Inc bought/maiden bought 48,901 shares at between 1.284USD and 1.297USD. The significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's di...
Guidewire Software Inc: 1 director
A director at Guidewire Software Inc sold 1,848 shares at 185.030USD and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
Klaviyo Inc: 1 director
A director at Klaviyo Inc sold 15,000 shares at 33.539USD and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
Skywater Technology Inc: 1 director
A director at Skywater Technology Inc sold 1,434,337 shares at 8.200USD and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...
GR Sarantis S.A.: 1 director
A director at GR Sarantis S.A. bought 1,500 shares at 12.640EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.